Search results
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 5 days agoDepemokimab could be the first approved drug to allow a long-term dosing interval, requiring only...
GSK finds success in severe asthma drug trials
Becker’s Hospital Review· 5 days agoAfter positive results in phase 3 trials, a GSK experimental therapy could be the first ultra-long-acting biologic approved for severe asthma. The drug ...
I Hate Summer—and You Should Too
Time Magazine· 2 hours agoSummertime is the season of horribles, from higher crime rates, to increased warfare, to spikes in asthma, to raging wildfires, to swarms of bugs, to a...
SMART Inhalers: The Overlooked Solution in Asthma Management
SciTechDaily· 5 days agoAccording to research presented at the ATS 2024 International Conference, only 14.5 percent of adult...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks· 5 days agoGSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 5 days ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
Too Few Asthma Patients Are Using Updated Inhalers
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoImproved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hardly anyone’s using them. The new...
Potential blockbuster asthma drug met goals in trials, GSK says
Morningstar· 5 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both ...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 5 days agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via Yahoo News· 5 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...
